scholarly article | Q13442814 |
review article | Q7318358 |
P356 | DOI | 10.1016/J.BBMT.2003.12.004 |
P698 | PubMed publication ID | 15205665 |
P50 | author | Don J. Diamond | Q37374385 |
Simon F Lacey | Q56978267 | ||
P2093 | author name string | John A Zaia | |
P433 | issue | 7 | |
P921 | main subject | Cytomegalovirus | Q6946 |
P304 | page(s) | 433-447 | |
P577 | publication date | 2004-07-01 | |
P1433 | published in | Biology of Blood and Marrow Transplantation | Q15754328 |
P1476 | title | Assessment of cellular immunity to human cytomegalovirus in recipients of allogeneic stem cell transplants | |
P478 | volume | 10 |
Q37213897 | Biologic and immunologic effects of knockout of human cytomegalovirus pp65 nuclear localization signal |
Q34104346 | CD154 expression is associated with neutralizing antibody titer levels postinfluenza vaccination in stem cell transplant patients and healthy adults |
Q47111092 | Comprehensive Analysis of Cytomegalovirus pp65 Antigen-Specific CD8+ T Cell Responses According to Human Leukocyte Antigen Class I Allotypes and Intraindividual Dominance |
Q92446001 | Cytomegalovirus Infections after Hematopoietic Stem Cell Transplantation: Current Status and Future Immunotherapy |
Q37559627 | Cytomegalovirus and varicella-zoster virus vaccines in hematopoietic stem cell transplantation |
Q35613340 | Cytomegalovirus viral load and virus-specific immune reconstitution after peripheral blood stem cell versus bone marrow transplantation |
Q53660426 | Evaluation of cytomegalovirus-specific cytotoxic T-lymphocytes in patients with the HLA-A*02 or HLA-A*24 phenotype undergoing hematopoietic stem cell transplantation. |
Q53557075 | Ex vivo monitoring of human cytomegalovirus-specific CD8+ T-cell responses using QuantiFERON-CMV. |
Q37237427 | How we treat cytomegalovirus in hematopoietic cell transplant recipients |
Q35965038 | Human cytomegalovirus: clinical aspects, immune regulation, and emerging treatments. |
Q50551600 | Human metapneumovirus infection after allogeneic hematopoietic stem cell transplantation. |
Q28072627 | Immune Reconstitution after Allogeneic Hematopoietic Stem Cell Transplantation |
Q35958223 | Immunotherapy with Donor T Cells Sensitized with Overlapping Pentadecapeptides for Treatment of Persistent Cytomegalovirus Infection or Viremia |
Q37159243 | Induction of alloanergy in human donor T cells without loss of pathogen or tumor immunity |
Q36043642 | Late-onset cytomegalovirus disease as a significant complication in solid organ transplant recipients receiving antiviral prophylaxis: a call to heed the mounting evidence |
Q36612933 | Longitudinal Kinetics of Cytomegalovirus-Specific T-Cell Immunity and Viral Replication in Infants With Congenital Cytomegalovirus Infection |
Q37888687 | Natural and adoptive T-cell immunity against herpes family viruses after allogeneic hematopoietic stem cell transplantation |
Q42220503 | Preliminary exploration of HLA-A 1101-restricted human cytomegalovirus glycoprotein B-specific CD8⁺ T cells in allogeneic stem-cell transplant recipients |
Q36190463 | Procedure for preparing peptide-major histocompatibility complex tetramers for direct quantification of antigen-specific cytotoxic T lymphocytes |
Q40202358 | Spontaneous resolution of post-transplant localized cytomegalovirus lymphadenitis mimicking tumor recurrence |
Q36099296 | Symptomatic and asymptomatic viral recrudescence in solid-organ transplant recipients and its relationship with the antigen-specific CD8(+) T-cell response |
Q55025898 | The Detailed Kinetics of Cytomegalovirus-specific T cell Responses after Hematopoietic Stem Cell Transplantation: 1 Year Follow-up Data. |
Q37460362 | The transfer of adaptive immunity to CMV during hematopoietic stem cell transplantation is dependent on the specificity and phenotype of CMV-specific T cells in the donor |
Q36839736 | Vaccine strategies against human cytomegalovirus infection. |
Search more.